Anupong Joompang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anupong Joompang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
La-Or Somsakeesit
Department of Chemistry, Faculty of Engineering, Rajamangala University of Technology Isan Khon Kaen Campus, Khon Kaen 40000, Thailand
2 shared publicationsSanti Phosri
Department of Chemical Engineering, Faculty of Engineering, Burapha University, Chon Buri 20131, Thailand
2 shared publications- Alisa Naladta
Faculty of Sciences, Khon Kaen University, Khon Kaen 40002, Thailand
1 shared publication Chanokbhorn Phaosiri
Natural Products Research Unit, Department of Chemistry, Faculty of Science, Khon Kaen University, Khon Kaen, 40002 Thailand
1 shared publicationKulwara Poolpol
Faculty of Allied Health Sciences, Burapha University, Chon Buri 20131, Thailand
1 shared publication- Lapatrada Taemaitree
Department of Integrated Science, Faculty of Science, Khon Kaen University, Khon Kaen, 40002, Thailand
1 shared publication
Latest Publications
- Open Access
- 5 August 2025
- Published by College of Graduate Studies, Walailak University in Trends in Sciences
- Vol. 22 (11) , 10745
Evaluation of Tyrosinase Inhibitory and Antioxidant Activity of Bis(carboxymethoxy) Curcumin Derivatives
Hyperpigmentation disorders are associated with various psychological health concerns and increased risk of skin cancer. Among potential therapeutic approaches, tyrosinase inhibitors represent promising candidates for treating these concerns. This study investigated the tyrosinase inhibitory activity and mechanisms of bis(carboxymethoxy) bismethoxycurcumin (4x), bis(carboxymethoxy) demethoxycurcumin (5v), and bis(carboxymethoxy) bisdemethoxycurcumin (6d). The results showed that 4x exhibited superior tyrosinase inhibitory activity across the tested concentrations (75 - 600 µM), decreasing enzyme activity to 78.52% - 36.72%, relative to 100% of the control, with an IC50 value of 272.85 µM. This compound also demonstrated the highest antioxidant activity, with values of 1.61 µM Trolox equivalent per µM 4x against the ABTS radical. The modification with a carboxymethoxy (-OCH2COOH) group enhanced the tyrosinase inhibitory and ABTS radical scavenging activities, while the absence of a methoxy group reduced these inhibitory activities. Molecular docking analysis indicated that these compounds interacted directly with the tyrosinase active site. Stronger interactions with copper atoms at the active site led to increased tyrosinase inhibitory activity, while the methoxy group proved significant for the tyrosinase inhibitory activity of 4x. Based on its superior inhibitory activity, 4x was selected for further kinetic and melanin inhibition studies, which revealed it to be a competitive inhibitor of tyrosinase with a Ki of 42.38 µM. Moreover, this compound, at concentrations of 75 - 150 µM, reduced melanin content in B16F10 cells to 88.02% - 70.57% compared to 100% of the control, without inducing cytotoxicity. These results suggest that 4x represents a promising candidate for development as an anti-hyperpigmentation agent in both cosmetic and medical applications. HIGHLIGHTS Modification with the carboxymethoxy group significantly enhances the tyrosinase inhibitory activity of curcumin, with 4x exhibiting superior tyrosinase inhibitory and ABTS radical scavenging activities among the three modified curcuminoids, namely 4x, 5v, and 6d. The presence of the methoxy group is essential for the improved anti-tyrosinase and ABTS radical scavenging activities of 4x. 4x, functioning as a competitive inhibitor of tyrosinase and decreasing melanin production in B16F10 cells, emerges as a promising candidate for further research and development as an anti-hyperpigmentation agent. GRAPHICAL ABSTRACT
- 5 August 2025
- Published by College of Graduate Studies, Walailak University in Trends in Sciences
- Vol. 22 (11) , 10745
Open AccessEvaluation of Tyrosinase Inhibitory and Antioxidant Activity of Bis(carboxymethoxy) Curcumin Derivatives
Hyperpigmentation disorders are associated with various psychological health concerns and increased risk of skin cancer. Among potential therapeutic approaches, tyrosinase inhibitors represent promising candidates for treating these concerns. This study investigated the tyrosinase inhibitory activity and mechanisms of bis(carboxymethoxy) bismethoxycurcumin (4x), bis(carboxymethoxy) demethoxycurcumin (5v), and bis(carboxymethoxy) bisdemethoxycurcumin (6d). The results showed that 4x exhibited superior tyrosinase inhibitory activity across the tested concentrations (75 - 600 µM), decreasing enzyme activity to 78.52% - 36.72%, relative to 100% of the control, with an IC50 value of 272.85 µM. This compound also demonstrated the highest antioxidant activity, with values of 1.61 µM Trolox equivalent per µM 4x against the ABTS radical. The modification with a carboxymethoxy (-OCH2COOH) group enhanced the tyrosinase inhibitory and ABTS radical scavenging activities, while the absence of a methoxy group reduced these inhibitory activities. Molecular docking analysis indicated that these compounds interacted directly with the tyrosinase active site. Stronger interactions with copper atoms at the active site led to increased tyrosinase inhibitory activity, while the methoxy group proved significant for the tyrosinase inhibitory activity of 4x. Based on its superior inhibitory activity, 4x was selected for further kinetic and melanin inhibition studies, which revealed it to be a competitive inhibitor of tyrosinase with a Ki of 42.38 µM. Moreover, this compound, at concentrations of 75 - 150 µM, reduced melanin content in B16F10 cells to 88.02% - 70.57% compared to 100% of the control, without inducing cytotoxicity. These results suggest that 4x represents a promising candidate for development as an anti-hyperpigmentation agent in both cosmetic and medical applications. HIGHLIGHTS Modification with the carboxymethoxy group significantly enhances the tyrosinase inhibitory activity of curcumin, with 4x exhibiting superior tyrosinase inhibitory and ABTS radical scavenging activities among the three modified curcuminoids, namely 4x, 5v, and 6d. The presence of the methoxy group is essential for the improved anti-tyrosinase and ABTS radical scavenging activities of 4x. 4x, functioning as a competitive inhibitor of tyrosinase and decreasing melanin production in B16F10 cells, emerges as a promising candidate for further research and development as an anti-hyperpigmentation agent. GRAPHICAL ABSTRACT
- 25 April 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 766, 151895
Piperine derivative, (2E,4E)-5-(benzo[d][1,3]dioxol-5-yl)-N-(2-hydroxyphenyl)penta-2,4-dienamide, exerted cytotoxic activity toward MCF-7 breast cancer cells via Apoptosis: Gene expression and biomolecular change study
- 25 April 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 766, 151895
Piperine derivative, (2E,4E)-5-(benzo[d][1,3]dioxol-5-yl)-N-(2-hydroxyphenyl)penta-2,4-dienamide, exerted cytotoxic activity toward MCF-7 breast cancer cells via Apoptosis: Gene expression and biomolecular change study
- Open Access
Evaluation of TILI-2 as an Anti-Tyrosinase, Anti-Oxidative Agent and Its Role in Preventing Melanogenesis Using a Proteomics Approach
There is a desire to develop new molecules that can combat hyperpigmentation. To this end, the N-terminal cysteine-containing heptapeptide TILI-2 has shown promising preliminary results. In this work, the mechanism by which it works was evaluated using a series of biochemical assays focusing on known biochemical pathways, followed by LC-MS/MS proteomics to discover pathways that have not been considered before. We demonstrate that TILI-2 is a competitive inhibitor of tyrosinase’s monophenolase activity and it could potentially scavenge ABTS and DPPH radicals. It has a very low cytotoxicity up to 1400 µM against human fibroblast NFDH cells and macrophage-like RAW 264.7 cells. Our proteomics study revealed that another putative mechanism by which TILI-2 may reduce melanin production involves the disruption of the TGF-β signaling pathway in mouse B16F1 cells. This result suggests that TILI-2 has potential scope to be used as a depigmenting agent.
Open AccessEvaluation of TILI-2 as an Anti-Tyrosinase, Anti-Oxidative Agent and Its Role in Preventing Melanogenesis Using a Proteomics Approach
There is a desire to develop new molecules that can combat hyperpigmentation. To this end, the N-terminal cysteine-containing heptapeptide TILI-2 has shown promising preliminary results. In this work, the mechanism by which it works was evaluated using a series of biochemical assays focusing on known biochemical pathways, followed by LC-MS/MS proteomics to discover pathways that have not been considered before. We demonstrate that TILI-2 is a competitive inhibitor of tyrosinase’s monophenolase activity and it could potentially scavenge ABTS and DPPH radicals. It has a very low cytotoxicity up to 1400 µM against human fibroblast NFDH cells and macrophage-like RAW 264.7 cells. Our proteomics study revealed that another putative mechanism by which TILI-2 may reduce melanin production involves the disruption of the TGF-β signaling pathway in mouse B16F1 cells. This result suggests that TILI-2 has potential scope to be used as a depigmenting agent.